Escherichia coli K12 JM103 is a prokaryote that has multiple antibiotic resistances.
antibiotic resistance| @ref 20215 |
Last LPSN update
2026-02-09 11:18:43 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Enterobacterales |
| Family Enterobacteriaceae |
| Genus Escherichia |
| Species Escherichia coli |
| Full scientific name Escherichia coli (Migula 1895) Castellani and Chalmers 1919 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 1141 | Mineral medium M9 for E. coli JM strains (DSMZ Medium 382) | Medium recipe at MediaDive  | Name: Mineral medium M9 for E. coli JM strains (DSMZ Medium 382) Composition: Na2HPO4 6.0 g/l KH2PO4 3.0 g/l Glucose 2.0 g/l NH4Cl 1.0 g/l NaCl 0.5 g/l Thiamine-HCl x 2 H2O 0.373301 g/l MgSO4 0.12037 g/l CaCl2 0.011098 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 1141 | positive | growth | 37 |
| Test 1 | |
|---|---|
| @ref | 1141 |
| Medium | Mueller-Hinton Agar |
| Manual annotation | 1 |
| Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 24-26 |
| Ampicillin 10µg (disc) | 22 |
| Aztreonam 30µg (disc) | 40 |
| Bacitracin 10Unit | 0 |
| Cefalotin 30µg (disc) | 20-22 |
| Cefazolin 30µg (disc) | 30-32 |
| Cefotaxime 30µg (disc) | 42 |
| Ceftriaxone 30µg (disc) | 40 |
| Chloramphenicol 30µg (disc) | 26-28 |
| Clindamycin 10µg (disc) | 0 |
| Colistin 10µg (disc) | 16 |
| Doxycycline 30µg (disc) | 22 |
| Erythromycin 15µg (disc) | 12 |
| Fosfomycin 50µg (disc) | >50 |
| Gentamycin 10µg (disc) | |
| Imipenem 10µg (disc) | 36 |
| Kanamycin 30µg (disc) | 34 |
| Lincomycin 15µg (disc) | 0 |
| Linezolid 10µg (disc) | 0 |
| Mezlocillin 30µg (disc) | 30 |
| Moxifloxacin 5µg (disc) | 32 |
| Neomycin 30µg (disc) | 20 |
| Nitrofurantoin 100µg (disc) | 26 |
| Norfloxacin 10µg (disc) | 34 |
| Nystatin 100Unit | 0 |
| Ofloxacin 5µg (disc) | 32-34 |
| Oxacillin 5µg (disc) | 0 |
| Penicillin G 6µg (disc) | 0 |
| Pipemidic acid 20µg (disc) | 28 |
| Piperacillin/Tazobactam 40µg (disc) | 30-32 |
| Polymyxin B 300Unit | 16 |
| Quinupristin/Dalfopristin 15µg (disc) | 0 |
| Teicoplanin 30µg (disc) | 0 |
| Tetracycline 30µg (disc) | 30 |
| Ticarcillin 75µg (disc) | 34 |
| Vancomycin 30µg (disc) | 0 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68368 | 27613 ChEBI | amygdalin | - | fermentation | from API 20E |
| 68368 | 29016 ChEBI | arginine | - | hydrolysis | from API 20E |
| 68368 | 16947 ChEBI | citrate | - | assimilation | from API 20E |
| 68368 | 17634 ChEBI | D-glucose | + | fermentation | from API 20E |
| 68368 | 16899 ChEBI | D-mannitol | + | fermentation | from API 20E |
| 68368 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20E |
| 68368 | 30849 ChEBI | L-arabinose | + | fermentation | from API 20E |
| 68368 | 62345 ChEBI | L-rhamnose | + | fermentation | from API 20E |
| 68368 | 25094 ChEBI | lysine | + | degradation | from API 20E |
| 68368 | 17268 ChEBI | myo-inositol | - | fermentation | from API 20E |
| 68368 | 18257 ChEBI | ornithine | - | degradation | from API 20E |
| 68368 | 30911 ChEBI | sorbitol | + | fermentation | from API 20E |
| 68368 | 17992 ChEBI | sucrose | - | fermentation | from API 20E |
| 68368 | 27897 ChEBI | tryptophan | + | energy source | from API 20E |
| 68368 | 16199 ChEBI | urea | - | hydrolysis | from API 20E |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 1141 | 28669 | Bacitracin | 10 Unit | from Antibiotic test | |
| 1141 | 3745 | Clindamycin | 10 µg (disc) | from Antibiotic test | |
| 1141 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 1141 | 63607 | Linezolid | 10 µg (disc) | from Antibiotic test | |
| 1141 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 1141 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 1141 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 1141 | Quinupristin/Dalfopristin | 15 µg (disc) | from Antibiotic test | ||
| 1141 | 29687 | Teicoplanin | 30 µg (disc) | from Antibiotic test | |
| 1141 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68368 | arginine dihydrolase | - | 3.5.3.6 | from API 20E |
| 68368 | beta-galactosidase | - | 3.2.1.23 | from API 20E |
| 68368 | cytochrome oxidase | - | 1.9.3.1 | from API 20E |
| 68368 | gelatinase | - | from API 20E | |
| 68368 | lysine decarboxylase | + | 4.1.1.18 | from API 20E |
| 68368 | ornithine decarboxylase | - | 4.1.1.17 | from API 20E |
| 68368 | tryptophan deaminase | - | 4.1.99.1 | from API 20E |
| 68368 | urease | - | 3.5.1.5 | from API 20E |
| @ref | ONPG | ADH (Arg) | LDC (Lys) | ODC | CIT | H2S productionH2S | URE | TDA (Trp) | IND | Acetoin production (Voges Proskauer test)VP | GEL | GLU | MAN | INO | Sor | RHA | SAC | MEL | AMY | ARA | OX | Nitrite productionNO2 | Reduction to N2N2 | MotilityMOB | Growth on MacConkey mediumMAC | OF-O | OF-F | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1141 | - | - | + | - | - | - | - | - | + | - | - | + | + | - | + | + | - | - | - | + | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | |
| 1141 | - | - | + | - | - | - | - | - | + | - | - | + | + | - | + | + | - | + | - | + | - | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. |
| Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|
| In Situ Growth of Biocompatible Biogenic Silver Nanoparticles in Poly-Vinyl Alcohol Thin Film Matrix. | Lakkakula J, Divakaran D, Srivastava R, Ingle P, Gade A, Raut R. | IEEE Trans Nanobioscience | 10.1109/tnb.2022.3208310 | 2023 | |
| Biogenic Synthesis of Silver Nanoparticles Using Pantoea stewartii and Priestia aryabhattai and Their Antimicrobial, Larvicidal, Histopathological, and Biotoxicity Potential. | Wilson JJ, Harimuralikrishnaa T, Sivakumar T, Mahendran S, Ponmanickam P, Thangaraj R, Sevarkodiyone S, Alharbi NS, Kadaikunnan S, Venkidasamy B, Thiruvengadam M, Govindasamy R. | Bioengineering (Basel) | 10.3390/bioengineering10020248 | 2023 | |
| Biocompatible antimicrobial cotton fibres for healthcare industries: a biogenic approach for synthesis of bio-organic-coated silver nanoparticles. | Kashid SB, Lakkakula JR, Chauhan DS, Srivastava R, Raut RW. | IET Nanobiotechnol | 10.1049/iet-nbt.2017.0077 | 2017 | |
| Development and evaluation of oligonucleotide chip based on the 16S-23S rRNA gene spacer region for detection of pathogenic microorganisms associated with sepsis. | Kim CM, Song ES, Jang HJ, Kim HJ, Lee S, Shin JH, Kim SJ, Jeong SH, Jeong J, Koh K, Choi GE, Lee EY, Chang CL. | J Clin Microbiol | 10.1128/jcm.01130-09 | 2010 | |
| Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB). | Barros CHN, Fulaz S, Stanisic D, Tasic L. | Antibiotics (Basel) | 10.3390/antibiotics7030069 | 2018 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive4437.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License